# A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

> **NCT03271073** · PHASE2 · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT03271073
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-01
- **Primary completion:** 2018-07-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03271073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03271073, "A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03271073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*